Scott Wieland

Scott Wieland, PhD, MBA, is a seasoned professional in drug development and regulation with extensive experience in leadership roles across various organizations. Notable positions include Senior Vice President of Research & Development at Shasqi, Executive Vice President of Development at Nanobiotix, and Vice President of Global Drug Development at PRA Health Sciences. Scott's expertise encompasses clinical and regulatory affairs, demonstrated during tenures at CytRx Corporation, Accera, and Integrium. Scott holds a PhD and MA in Physiological Psychology from the University of Arizona, an MBA in Management from Webster University, and a BS in Physiological Psychology from UC Santa Barbara.